nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Injection site necrosis—Gemcitabine—pancreatic cancer	0.0331	0.107	CcSEcCtD
Terlipressin—Pasireotide—SSTR3—pancreatic cancer	0.00781	0.174	CrCbGaD
Terlipressin—Pasireotide—SSTR1—pancreatic cancer	0.00781	0.174	CrCbGaD
Terlipressin—Abdominal cramps—Tamoxifen—pancreatic cancer	0.00749	0.0242	CcSEcCtD
Terlipressin—Pasireotide—SSTR2—pancreatic cancer	0.00664	0.148	CrCbGaD
Terlipressin—Torsade de pointes—Sunitinib—pancreatic cancer	0.00617	0.0199	CcSEcCtD
Terlipressin—Octreotide—SSTR1—pancreatic cancer	0.00581	0.129	CrCbGaD
Terlipressin—Octreotide—SSTR3—pancreatic cancer	0.00581	0.129	CrCbGaD
Terlipressin—Vapreotide—SSTR2—pancreatic cancer	0.00565	0.126	CrCbGaD
Terlipressin—Abdominal cramps—Irinotecan—pancreatic cancer	0.00528	0.017	CcSEcCtD
Terlipressin—Octreotide—SSTR2—pancreatic cancer	0.00494	0.11	CrCbGaD
Terlipressin—Skin exfoliation—Tamoxifen—pancreatic cancer	0.00482	0.0156	CcSEcCtD
Terlipressin—Skin exfoliation—Erlotinib—pancreatic cancer	0.00477	0.0154	CcSEcCtD
Terlipressin—Skin necrosis—Epirubicin—pancreatic cancer	0.00476	0.0154	CcSEcCtD
Terlipressin—Respiratory failure—Sunitinib—pancreatic cancer	0.00441	0.0142	CcSEcCtD
Terlipressin—Skin necrosis—Doxorubicin—pancreatic cancer	0.0044	0.0142	CcSEcCtD
Terlipressin—Skin exfoliation—Sunitinib—pancreatic cancer	0.00413	0.0133	CcSEcCtD
Terlipressin—Hot flush—Tamoxifen—pancreatic cancer	0.00392	0.0127	CcSEcCtD
Terlipressin—Menopausal symptoms—Tamoxifen—pancreatic cancer	0.00389	0.0125	CcSEcCtD
Terlipressin—Pulmonary oedema—Sunitinib—pancreatic cancer	0.00385	0.0124	CcSEcCtD
Terlipressin—Respiratory failure—Gemcitabine—pancreatic cancer	0.00354	0.0114	CcSEcCtD
Terlipressin—Hot flush—Sunitinib—pancreatic cancer	0.00336	0.0108	CcSEcCtD
Terlipressin—Menopausal symptoms—Sunitinib—pancreatic cancer	0.00333	0.0107	CcSEcCtD
Terlipressin—Skin exfoliation—Gemcitabine—pancreatic cancer	0.00332	0.0107	CcSEcCtD
Terlipressin—Cardiac failure—Sunitinib—pancreatic cancer	0.00322	0.0104	CcSEcCtD
Terlipressin—Hyponatraemia—Sunitinib—pancreatic cancer	0.00315	0.0102	CcSEcCtD
Terlipressin—Pulmonary oedema—Gemcitabine—pancreatic cancer	0.00309	0.00998	CcSEcCtD
Terlipressin—Acute coronary syndrome—Tamoxifen—pancreatic cancer	0.00279	0.00899	CcSEcCtD
Terlipressin—Myocardial infarction—Tamoxifen—pancreatic cancer	0.00277	0.00894	CcSEcCtD
Terlipressin—Acute coronary syndrome—Erlotinib—pancreatic cancer	0.00276	0.0089	CcSEcCtD
Terlipressin—Myocardial infarction—Erlotinib—pancreatic cancer	0.00274	0.00885	CcSEcCtD
Terlipressin—Hyponatraemia—Irinotecan—pancreatic cancer	0.0026	0.00839	CcSEcCtD
Terlipressin—Cardiac failure—Gemcitabine—pancreatic cancer	0.00258	0.00834	CcSEcCtD
Terlipressin—Cardiac failure—Fluorouracil—pancreatic cancer	0.00254	0.0082	CcSEcCtD
Terlipressin—Respiratory failure—Docetaxel—pancreatic cancer	0.00251	0.0081	CcSEcCtD
Terlipressin—Acute coronary syndrome—Sunitinib—pancreatic cancer	0.00239	0.0077	CcSEcCtD
Terlipressin—Skin exfoliation—Docetaxel—pancreatic cancer	0.00235	0.00759	CcSEcCtD
Terlipressin—Bradycardia—Sunitinib—pancreatic cancer	0.00221	0.00714	CcSEcCtD
Terlipressin—Pulmonary oedema—Docetaxel—pancreatic cancer	0.00219	0.00708	CcSEcCtD
Terlipressin—Malnutrition—Erlotinib—pancreatic cancer	0.00219	0.00705	CcSEcCtD
Terlipressin—Cardiac disorder—Sunitinib—pancreatic cancer	0.00202	0.00651	CcSEcCtD
Terlipressin—Angiopathy—Sunitinib—pancreatic cancer	0.00197	0.00636	CcSEcCtD
Terlipressin—Acute coronary syndrome—Irinotecan—pancreatic cancer	0.00197	0.00635	CcSEcCtD
Terlipressin—Myocardial infarction—Irinotecan—pancreatic cancer	0.00196	0.00631	CcSEcCtD
Terlipressin—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.00192	0.00618	CcSEcCtD
Terlipressin—Hot flush—Docetaxel—pancreatic cancer	0.00191	0.00617	CcSEcCtD
Terlipressin—Hypertension—Tamoxifen—pancreatic cancer	0.00191	0.00616	CcSEcCtD
Terlipressin—Myocardial infarction—Gemcitabine—pancreatic cancer	0.0019	0.00615	CcSEcCtD
Terlipressin—Menopausal symptoms—Docetaxel—pancreatic cancer	0.0019	0.00612	CcSEcCtD
Terlipressin—Malnutrition—Sunitinib—pancreatic cancer	0.00189	0.00611	CcSEcCtD
Terlipressin—Atrial fibrillation—Docetaxel—pancreatic cancer	0.00189	0.00609	CcSEcCtD
Terlipressin—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.00188	0.00608	CcSEcCtD
Terlipressin—Chest pain—Tamoxifen—pancreatic cancer	0.00188	0.00607	CcSEcCtD
Terlipressin—Myocardial infarction—Fluorouracil—pancreatic cancer	0.00187	0.00604	CcSEcCtD
Terlipressin—Chest pain—Erlotinib—pancreatic cancer	0.00186	0.00601	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00185	0.00596	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Epirubicin—pancreatic cancer	0.00184	0.00594	CcSEcCtD
Terlipressin—Cardiac failure—Docetaxel—pancreatic cancer	0.00183	0.00592	CcSEcCtD
Terlipressin—Bradycardia—Irinotecan—pancreatic cancer	0.00182	0.00588	CcSEcCtD
Terlipressin—Hyponatraemia—Docetaxel—pancreatic cancer	0.0018	0.0058	CcSEcCtD
Terlipressin—Nervous system disorder—Erlotinib—pancreatic cancer	0.00175	0.00565	CcSEcCtD
Terlipressin—Skin disorder—Erlotinib—pancreatic cancer	0.00173	0.00559	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Doxorubicin—pancreatic cancer	0.0017	0.0055	CcSEcCtD
Terlipressin—Cardiac disorder—Irinotecan—pancreatic cancer	0.00166	0.00536	CcSEcCtD
Terlipressin—Hypertension—Sunitinib—pancreatic cancer	0.00163	0.00527	CcSEcCtD
Terlipressin—Angiopathy—Irinotecan—pancreatic cancer	0.00162	0.00524	CcSEcCtD
Terlipressin—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00162	0.00522	CcSEcCtD
Terlipressin—Chest pain—Sunitinib—pancreatic cancer	0.00161	0.0052	CcSEcCtD
Terlipressin—Dyspnoea—Tamoxifen—pancreatic cancer	0.00161	0.00519	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.0016	0.00516	CcSEcCtD
Terlipressin—Dyspnoea—Erlotinib—pancreatic cancer	0.00159	0.00513	CcSEcCtD
Terlipressin—Skin exfoliation—Epirubicin—pancreatic cancer	0.00159	0.00512	CcSEcCtD
Terlipressin—Angiopathy—Gemcitabine—pancreatic cancer	0.00158	0.00511	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00156	0.00502	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00154	0.00497	CcSEcCtD
Terlipressin—Nervous system disorder—Sunitinib—pancreatic cancer	0.00151	0.00489	CcSEcCtD
Terlipressin—Skin disorder—Sunitinib—pancreatic cancer	0.0015	0.00484	CcSEcCtD
Terlipressin—Pulmonary oedema—Epirubicin—pancreatic cancer	0.00148	0.00478	CcSEcCtD
Terlipressin—Skin exfoliation—Doxorubicin—pancreatic cancer	0.00147	0.00474	CcSEcCtD
Terlipressin—Abdominal pain—Tamoxifen—pancreatic cancer	0.00143	0.0046	CcSEcCtD
Terlipressin—Abdominal pain—Erlotinib—pancreatic cancer	0.00141	0.00455	CcSEcCtD
Terlipressin—Dyspnoea—Sunitinib—pancreatic cancer	0.00138	0.00444	CcSEcCtD
Terlipressin—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.00137	0.00442	CcSEcCtD
Terlipressin—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00136	0.00439	CcSEcCtD
Terlipressin—Myocardial infarction—Docetaxel—pancreatic cancer	0.00135	0.00436	CcSEcCtD
Terlipressin—Hypertension—Irinotecan—pancreatic cancer	0.00135	0.00434	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00133	0.0043	CcSEcCtD
Terlipressin—Hypertension—Gemcitabine—pancreatic cancer	0.00131	0.00423	CcSEcCtD
Terlipressin—Chest pain—Gemcitabine—pancreatic cancer	0.00129	0.00417	CcSEcCtD
Terlipressin—Hot flush—Epirubicin—pancreatic cancer	0.00129	0.00416	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00128	0.00414	CcSEcCtD
Terlipressin—Menopausal symptoms—Epirubicin—pancreatic cancer	0.00128	0.00413	CcSEcCtD
Terlipressin—Chest pain—Fluorouracil—pancreatic cancer	0.00127	0.0041	CcSEcCtD
Terlipressin—Nervous system disorder—Irinotecan—pancreatic cancer	0.00125	0.00403	CcSEcCtD
Terlipressin—Cardiac failure—Epirubicin—pancreatic cancer	0.00124	0.00399	CcSEcCtD
Terlipressin—Diarrhoea—Tamoxifen—pancreatic cancer	0.00123	0.00398	CcSEcCtD
Terlipressin—Abdominal pain—Sunitinib—pancreatic cancer	0.00122	0.00394	CcSEcCtD
Terlipressin—Diarrhoea—Erlotinib—pancreatic cancer	0.00122	0.00394	CcSEcCtD
Terlipressin—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00122	0.00392	CcSEcCtD
Terlipressin—Hyponatraemia—Epirubicin—pancreatic cancer	0.00121	0.00391	CcSEcCtD
Terlipressin—Skin disorder—Gemcitabine—pancreatic cancer	0.0012	0.00388	CcSEcCtD
Terlipressin—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00119	0.00386	CcSEcCtD
Terlipressin—Hot flush—Doxorubicin—pancreatic cancer	0.00119	0.00385	CcSEcCtD
Terlipressin—Tachycardia—Fluorouracil—pancreatic cancer	0.00119	0.00384	CcSEcCtD
Terlipressin—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.00118	0.00382	CcSEcCtD
Terlipressin—Cardiac disorder—Docetaxel—pancreatic cancer	0.00115	0.00371	CcSEcCtD
Terlipressin—Vomiting—Tamoxifen—pancreatic cancer	0.00115	0.0037	CcSEcCtD
Terlipressin—Cardiac failure—Doxorubicin—pancreatic cancer	0.00114	0.00369	CcSEcCtD
Terlipressin—Vomiting—Erlotinib—pancreatic cancer	0.00113	0.00366	CcSEcCtD
Terlipressin—Dyspnoea—Irinotecan—pancreatic cancer	0.00113	0.00366	CcSEcCtD
Terlipressin—Headache—Tamoxifen—pancreatic cancer	0.00113	0.00365	CcSEcCtD
Terlipressin—Angiopathy—Docetaxel—pancreatic cancer	0.00112	0.00362	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00112	0.00362	CcSEcCtD
Terlipressin—Headache—Erlotinib—pancreatic cancer	0.00112	0.00361	CcSEcCtD
Terlipressin—Dyspnoea—Gemcitabine—pancreatic cancer	0.0011	0.00357	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.0011	0.00354	CcSEcCtD
Terlipressin—Dyspnoea—Fluorouracil—pancreatic cancer	0.00109	0.00351	CcSEcCtD
Terlipressin—Malnutrition—Docetaxel—pancreatic cancer	0.00108	0.00348	CcSEcCtD
Terlipressin—Nausea—Tamoxifen—pancreatic cancer	0.00107	0.00346	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00107	0.00345	CcSEcCtD
Terlipressin—Nausea—Erlotinib—pancreatic cancer	0.00106	0.00342	CcSEcCtD
Terlipressin—Diarrhoea—Sunitinib—pancreatic cancer	0.00106	0.00341	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00105	0.00339	CcSEcCtD
Terlipressin—Abdominal pain—Irinotecan—pancreatic cancer	0.00101	0.00325	CcSEcCtD
Terlipressin—Vomiting—Sunitinib—pancreatic cancer	0.000982	0.00317	CcSEcCtD
Terlipressin—Headache—Sunitinib—pancreatic cancer	0.000967	0.00312	CcSEcCtD
Terlipressin—Hypertension—Docetaxel—pancreatic cancer	0.00093	0.003	CcSEcCtD
Terlipressin—Chest pain—Docetaxel—pancreatic cancer	0.000917	0.00296	CcSEcCtD
Terlipressin—Nausea—Sunitinib—pancreatic cancer	0.000917	0.00296	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000911	0.00294	CcSEcCtD
Terlipressin—Diarrhoea—Irinotecan—pancreatic cancer	0.00087	0.00281	CcSEcCtD
Terlipressin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000862	0.00278	CcSEcCtD
Terlipressin—Tachycardia—Docetaxel—pancreatic cancer	0.000858	0.00277	CcSEcCtD
Terlipressin—Skin disorder—Docetaxel—pancreatic cancer	0.000854	0.00276	CcSEcCtD
Terlipressin—Bradycardia—Epirubicin—pancreatic cancer	0.00085	0.00274	CcSEcCtD
Terlipressin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000848	0.00274	CcSEcCtD
Terlipressin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000834	0.00269	CcSEcCtD
Terlipressin—Vomiting—Irinotecan—pancreatic cancer	0.000809	0.00261	CcSEcCtD
Terlipressin—Headache—Irinotecan—pancreatic cancer	0.000797	0.00257	CcSEcCtD
Terlipressin—Vomiting—Gemcitabine—pancreatic cancer	0.000788	0.00254	CcSEcCtD
Terlipressin—Bradycardia—Doxorubicin—pancreatic cancer	0.000786	0.00254	CcSEcCtD
Terlipressin—Dyspnoea—Docetaxel—pancreatic cancer	0.000784	0.00253	CcSEcCtD
Terlipressin—Headache—Gemcitabine—pancreatic cancer	0.000776	0.00251	CcSEcCtD
Terlipressin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000775	0.0025	CcSEcCtD
Terlipressin—Vomiting—Fluorouracil—pancreatic cancer	0.000775	0.0025	CcSEcCtD
Terlipressin—Headache—Fluorouracil—pancreatic cancer	0.000763	0.00246	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000759	0.00245	CcSEcCtD
Terlipressin—Angiopathy—Epirubicin—pancreatic cancer	0.000757	0.00244	CcSEcCtD
Terlipressin—Nausea—Irinotecan—pancreatic cancer	0.000756	0.00244	CcSEcCtD
Terlipressin—Nausea—Gemcitabine—pancreatic cancer	0.000736	0.00238	CcSEcCtD
Terlipressin—Malnutrition—Epirubicin—pancreatic cancer	0.000727	0.00235	CcSEcCtD
Terlipressin—Nausea—Fluorouracil—pancreatic cancer	0.000724	0.00234	CcSEcCtD
Terlipressin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000717	0.00231	CcSEcCtD
Terlipressin—Angiopathy—Doxorubicin—pancreatic cancer	0.000701	0.00226	CcSEcCtD
Terlipressin—Abdominal pain—Docetaxel—pancreatic cancer	0.000695	0.00224	CcSEcCtD
Terlipressin—Malnutrition—Doxorubicin—pancreatic cancer	0.000672	0.00217	CcSEcCtD
Terlipressin—Hypertension—Epirubicin—pancreatic cancer	0.000627	0.00202	CcSEcCtD
Terlipressin—Chest pain—Epirubicin—pancreatic cancer	0.000619	0.002	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000614	0.00198	CcSEcCtD
Terlipressin—Diarrhoea—Docetaxel—pancreatic cancer	0.000602	0.00194	CcSEcCtD
Terlipressin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000582	0.00188	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—pancreatic cancer	0.000581	0.00187	CcSEcCtD
Terlipressin—Tachycardia—Epirubicin—pancreatic cancer	0.000579	0.00187	CcSEcCtD
Terlipressin—Skin disorder—Epirubicin—pancreatic cancer	0.000576	0.00186	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—pancreatic cancer	0.000572	0.00185	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000569	0.00183	CcSEcCtD
Terlipressin—Vomiting—Docetaxel—pancreatic cancer	0.000559	0.0018	CcSEcCtD
Terlipressin—Headache—Docetaxel—pancreatic cancer	0.000551	0.00178	CcSEcCtD
Terlipressin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000538	0.00174	CcSEcCtD
Terlipressin—Tachycardia—Doxorubicin—pancreatic cancer	0.000536	0.00173	CcSEcCtD
Terlipressin—Skin disorder—Doxorubicin—pancreatic cancer	0.000533	0.00172	CcSEcCtD
Terlipressin—Dyspnoea—Epirubicin—pancreatic cancer	0.000529	0.00171	CcSEcCtD
Terlipressin—Nausea—Docetaxel—pancreatic cancer	0.000522	0.00169	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000512	0.00165	CcSEcCtD
Terlipressin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000489	0.00158	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—SSTR3—pancreatic cancer	0.000481	0.000746	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—SST—pancreatic cancer	0.000475	0.000735	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000474	0.00153	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CNR2—pancreatic cancer	0.000472	0.000732	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GLP1R—pancreatic cancer	0.000472	0.000732	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CXCL8—pancreatic cancer	0.000472	0.000731	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PTHLH—pancreatic cancer	0.000471	0.00073	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PTCH1—pancreatic cancer	0.000471	0.00073	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—SST—pancreatic cancer	0.000471	0.00073	CbGpPWpGaD
Terlipressin—Abdominal pain—Epirubicin—pancreatic cancer	0.000469	0.00151	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000468	0.000725	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000468	0.000725	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000465	0.000721	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SSTR1—pancreatic cancer	0.000465	0.00072	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCKAR—pancreatic cancer	0.000465	0.00072	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SSTR1—pancreatic cancer	0.000461	0.000715	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PPY—pancreatic cancer	0.000456	0.000706	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PPY—pancreatic cancer	0.000452	0.000701	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JAG2—pancreatic cancer	0.00045	0.000698	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SSTR2—pancreatic cancer	0.000447	0.000693	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MEN1—pancreatic cancer	0.000444	0.000688	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SSTR2—pancreatic cancer	0.000444	0.000688	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CNR1—pancreatic cancer	0.000438	0.000679	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000435	0.000674	CbGpPWpGaD
Terlipressin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000434	0.0014	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—CCKBR—pancreatic cancer	0.000432	0.000669	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—SST—pancreatic cancer	0.000431	0.000668	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00043	0.000666	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCKBR—pancreatic cancer	0.000429	0.000664	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—SST—pancreatic cancer	0.000428	0.000663	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000426	0.000661	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000424	0.000657	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SHH—pancreatic cancer	0.000424	0.000656	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—GCG—pancreatic cancer	0.000423	0.000655	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOTCH4—pancreatic cancer	0.000421	0.000652	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—GCG—pancreatic cancer	0.00042	0.000651	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IAPP—pancreatic cancer	0.000418	0.000648	CbGpPWpGaD
Terlipressin—AVPR1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000411	0.000638	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—DTX4—pancreatic cancer	0.000406	0.000629	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GLI1—pancreatic cancer	0.000406	0.000629	CbGpPWpGaD
Terlipressin—Diarrhoea—Epirubicin—pancreatic cancer	0.000406	0.00131	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000403	0.000625	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GLI1—pancreatic cancer	0.000403	0.000625	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—DTX4—pancreatic cancer	0.000403	0.000625	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTHLH—pancreatic cancer	0.000402	0.000622	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTCH1—pancreatic cancer	0.000402	0.000622	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000401	0.000621	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000401	0.000621	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CNR1—pancreatic cancer	0.000398	0.000616	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NRP1—pancreatic cancer	0.000395	0.000612	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000395	0.000612	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CNR1—pancreatic cancer	0.000395	0.000612	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NRP1—pancreatic cancer	0.000392	0.000608	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000392	0.000608	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—GCG—pancreatic cancer	0.000384	0.000595	CbGpPWpGaD
Terlipressin—Desmopressin—PTGS2—pancreatic cancer	0.000384	0.00856	CrCbGaD
Terlipressin—AVPR2—Signaling by GPCR—GCG—pancreatic cancer	0.000381	0.000591	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HEY2—pancreatic cancer	0.00038	0.000589	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HEY2—pancreatic cancer	0.000378	0.000585	CbGpPWpGaD
Terlipressin—Vomiting—Epirubicin—pancreatic cancer	0.000377	0.00122	CcSEcCtD
Terlipressin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000375	0.00121	CcSEcCtD
Terlipressin—Headache—Epirubicin—pancreatic cancer	0.000372	0.0012	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—GAST—pancreatic cancer	0.000371	0.000576	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GAST—pancreatic cancer	0.000369	0.000571	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000368	0.00057	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SST—pancreatic cancer	0.000367	0.000569	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AGTR1—pancreatic cancer	0.000366	0.000568	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000364	0.000564	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000362	0.000561	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JAG1—pancreatic cancer	0.000359	0.000557	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOTCH3—pancreatic cancer	0.000358	0.000555	CbGpPWpGaD
Terlipressin—Nausea—Epirubicin—pancreatic cancer	0.000352	0.00114	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—SCT—pancreatic cancer	0.000352	0.000546	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HEY1—pancreatic cancer	0.000352	0.000546	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SCT—pancreatic cancer	0.00035	0.000542	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HEY1—pancreatic cancer	0.00035	0.000542	CbGpPWpGaD
Terlipressin—Vomiting—Doxorubicin—pancreatic cancer	0.000349	0.00113	CcSEcCtD
Terlipressin—Headache—Doxorubicin—pancreatic cancer	0.000344	0.00111	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.00034	0.000528	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CNR1—pancreatic cancer	0.000339	0.000525	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCK—pancreatic cancer	0.000336	0.00052	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCK—pancreatic cancer	0.000333	0.000517	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000329	0.00051	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GCG—pancreatic cancer	0.000327	0.000507	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CNR2—pancreatic cancer	0.000327	0.000507	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GLP1R—pancreatic cancer	0.000327	0.000507	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CXCL8—pancreatic cancer	0.000327	0.000507	CbGpPWpGaD
Terlipressin—Nausea—Doxorubicin—pancreatic cancer	0.000326	0.00105	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—CNR2—pancreatic cancer	0.000325	0.000504	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GLP1R—pancreatic cancer	0.000325	0.000504	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000325	0.000503	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000322	0.000499	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCKAR—pancreatic cancer	0.00032	0.000495	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000318	0.000493	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AGTR1—pancreatic cancer	0.000312	0.000484	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JAG2—pancreatic cancer	0.000312	0.000484	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JAG2—pancreatic cancer	0.00031	0.00048	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STK11—pancreatic cancer	0.000308	0.000477	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MEN1—pancreatic cancer	0.000308	0.000477	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MEN1—pancreatic cancer	0.000306	0.000473	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SHH—pancreatic cancer	0.000294	0.000455	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000292	0.000452	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SHH—pancreatic cancer	0.000291	0.000452	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IAPP—pancreatic cancer	0.00029	0.000449	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH4—pancreatic cancer	0.00029	0.000449	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000289	0.000448	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IAPP—pancreatic cancer	0.000288	0.000446	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTHLH—pancreatic cancer	0.000278	0.000431	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTCH1—pancreatic cancer	0.000278	0.000431	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000278	0.00043	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTCH1—pancreatic cancer	0.000276	0.000428	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTHLH—pancreatic cancer	0.000276	0.000428	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SMAD4—pancreatic cancer	0.00027	0.000418	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000267	0.000413	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HES1—pancreatic cancer	0.000263	0.000408	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SST—pancreatic cancer	0.000255	0.000394	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SST—pancreatic cancer	0.000253	0.000392	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000252	0.000391	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000251	0.000389	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000249	0.000386	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JAG1—pancreatic cancer	0.000249	0.000386	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000248	0.000384	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JAG1—pancreatic cancer	0.000247	0.000383	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000246	0.000382	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL8—pancreatic cancer	0.000242	0.000375	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CNR1—pancreatic cancer	0.000235	0.000364	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CNR1—pancreatic cancer	0.000233	0.000361	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TERT—pancreatic cancer	0.000231	0.000357	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000228	0.000353	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GCG—pancreatic cancer	0.000227	0.000352	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000226	0.000351	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GCG—pancreatic cancer	0.000225	0.000349	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000221	0.000342	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HIF1A—pancreatic cancer	0.000221	0.000342	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TSC2—pancreatic cancer	0.00022	0.000341	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000219	0.00034	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000216	0.000335	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOE—pancreatic cancer	0.000215	0.000334	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AGTR1—pancreatic cancer	0.000215	0.000333	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STK11—pancreatic cancer	0.000213	0.000331	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STK11—pancreatic cancer	0.000212	0.000328	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KDR—pancreatic cancer	0.000211	0.000327	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NFKBIA—pancreatic cancer	0.000201	0.000311	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.0002	0.000311	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000199	0.000308	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOTCH1—pancreatic cancer	0.000199	0.000308	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—pancreatic cancer	0.000194	0.000301	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—NRAS—pancreatic cancer	0.000194	0.000301	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000192	0.000298	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGF—pancreatic cancer	0.000192	0.000298	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000191	0.000296	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SMAD4—pancreatic cancer	0.000187	0.00029	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SMAD4—pancreatic cancer	0.000185	0.000287	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000185	0.000286	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000184	0.000284	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HES1—pancreatic cancer	0.000182	0.000283	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HES1—pancreatic cancer	0.000181	0.000281	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EGFR—pancreatic cancer	0.000177	0.000274	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000175	0.000271	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000173	0.000269	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CD—pancreatic cancer	0.000171	0.000265	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000169	0.000262	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000168	0.00026	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—pancreatic cancer	0.000167	0.000259	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000167	0.000258	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TERT—pancreatic cancer	0.00016	0.000248	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TERT—pancreatic cancer	0.000159	0.000246	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000154	0.000238	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HIF1A—pancreatic cancer	0.000153	0.000237	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TSC2—pancreatic cancer	0.000152	0.000236	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HIF1A—pancreatic cancer	0.000152	0.000235	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TSC2—pancreatic cancer	0.000151	0.000235	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOE—pancreatic cancer	0.000149	0.000231	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CB—pancreatic cancer	0.000149	0.000231	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOE—pancreatic cancer	0.000148	0.00023	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KDR—pancreatic cancer	0.000146	0.000227	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KDR—pancreatic cancer	0.000145	0.000225	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL8—pancreatic cancer	0.000143	0.000222	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—HRAS—pancreatic cancer	0.000142	0.00022	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000139	0.000215	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—pancreatic cancer	0.000138	0.000214	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000138	0.000214	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000138	0.000213	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—pancreatic cancer	0.000137	0.000212	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000137	0.000212	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000135	0.000209	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—NRAS—pancreatic cancer	0.000135	0.000209	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000134	0.000207	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—NRAS—pancreatic cancer	0.000134	0.000207	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—pancreatic cancer	0.000133	0.000207	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGF—pancreatic cancer	0.000133	0.000206	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGF—pancreatic cancer	0.000132	0.000205	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CTNNB1—pancreatic cancer	0.000132	0.000205	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—pancreatic cancer	0.000129	0.000201	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTEN—pancreatic cancer	0.000129	0.000199	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—pancreatic cancer	0.000126	0.000194	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EGFR—pancreatic cancer	0.000123	0.00019	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EGFR—pancreatic cancer	0.000122	0.000189	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SRC—pancreatic cancer	0.000119	0.000185	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000118	0.000183	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000118	0.000182	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000117	0.000182	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000116	0.00018	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—pancreatic cancer	0.000116	0.00018	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—pancreatic cancer	0.000116	0.00018	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—pancreatic cancer	0.000115	0.000178	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—pancreatic cancer	0.000115	0.000178	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NRAS—pancreatic cancer	0.000115	0.000178	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—pancreatic cancer	0.000107	0.000166	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—pancreatic cancer	0.000107	0.000165	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000106	0.000165	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000106	0.000164	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGFR—pancreatic cancer	0.000105	0.000162	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000103	0.00016	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000102	0.000159	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL8—pancreatic cancer	9.92e-05	0.000154	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—pancreatic cancer	9.88e-05	0.000153	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HRAS—pancreatic cancer	9.85e-05	0.000153	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL8—pancreatic cancer	9.85e-05	0.000153	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HRAS—pancreatic cancer	9.78e-05	0.000152	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—pancreatic cancer	9.58e-05	0.000148	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—pancreatic cancer	9.51e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—pancreatic cancer	9.49e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—pancreatic cancer	9.42e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—pancreatic cancer	9.24e-05	0.000143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—pancreatic cancer	9.17e-05	0.000142	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CTNNB1—pancreatic cancer	9.15e-05	0.000142	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CTNNB1—pancreatic cancer	9.08e-05	0.000141	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—pancreatic cancer	9.08e-05	0.000141	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—pancreatic cancer	8.97e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTEN—pancreatic cancer	8.92e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—pancreatic cancer	8.91e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTEN—pancreatic cancer	8.85e-05	0.000137	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—pancreatic cancer	8.78e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—pancreatic cancer	8.7e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—pancreatic cancer	8.64e-05	0.000134	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HRAS—pancreatic cancer	8.4e-05	0.00013	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SRC—pancreatic cancer	8.27e-05	0.000128	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SRC—pancreatic cancer	8.21e-05	0.000127	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—pancreatic cancer	8.05e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—pancreatic cancer	8e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—pancreatic cancer	7.98e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NRAS—pancreatic cancer	7.96e-05	0.000123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—pancreatic cancer	7.92e-05	0.000123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NRAS—pancreatic cancer	7.9e-05	0.000122	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—pancreatic cancer	7.41e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—pancreatic cancer	7.41e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—pancreatic cancer	7.39e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—pancreatic cancer	7.36e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—pancreatic cancer	7.34e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGFR—pancreatic cancer	7.25e-05	0.000112	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGFR—pancreatic cancer	7.2e-05	0.000112	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—pancreatic cancer	6.85e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—pancreatic cancer	6.8e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—pancreatic cancer	6.29e-05	9.75e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—pancreatic cancer	6.25e-05	9.68e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—pancreatic cancer	6.09e-05	9.43e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—pancreatic cancer	6.04e-05	9.36e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HRAS—pancreatic cancer	5.82e-05	9.02e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HRAS—pancreatic cancer	5.78e-05	8.95e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—pancreatic cancer	5.14e-05	7.96e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—pancreatic cancer	5.1e-05	7.91e-05	CbGpPWpGaD
